{"pageContent": "Objective: Androgen deprivation therapy (ADT) is the primary treatment for advanced prostate cancer (CaP). There is growing evidence that ADT negatively affects men's psychosocial well-being (e.g., causing sexual dysfunction, bodily feminization) and physical health (e.g., increasing the risk of osteoporosis and metabolic syndrome). Although strategies for managing the majority of side effects exist, it is not clear that patients are benefiting from this knowledge.", "metaData": {"source": "Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment\nhttps://pubmed.ncbi.nlm.nih.gov/20921463/"}}